axicabtagene ciloleucel
daiichi sankyo,gilead
['axi-cel', 'dlbcl', 'lymphoma', 'lymsm']
somewhat argues to pre-bridge (pola-r) to get to 2l #cart #dlbcl. often have to anyway #lymphoma #lymsm #ash22 
Lymphoma Program Director, Colorado Blood Cancer Institute #lymphoma #lymsm #celltherapy #CART #autoimmune #BMT @CBCIDocs @ColoradoBlood ?????? opinions my own